272 related articles for article (PubMed ID: 18540332)
41. Therapy of angina pectoris with long-acting nitrates: which agent and when?
Abrams J
Can J Cardiol; 1996 May; 12 Suppl C():9C-16C. PubMed ID: 8634922
[TBL] [Abstract][Full Text] [Related]
42. [Tolerance or hemodynamic adaptation during nitrate therapy].
Rietbrock N; Woodcock BG
Dtsch Med Wochenschr; 1984 Feb; 109(5):163-5. PubMed ID: 6697904
[No Abstract] [Full Text] [Related]
43. [Development and status of nitrate therapy in East Germany].
Engelmann L; Wetzler G; Kucher A; Frömmel H
Z Kardiol; 1989; 78 Suppl 2():99-101; discussion 115-7. PubMed ID: 2511700
[TBL] [Abstract][Full Text] [Related]
44. [Combination therapy of angina pectoris vera with coronary active substances and Faustan].
Nossing R; Gruber G; Schmidt P
Z Arztl Fortbild (Jena); 1971 Jun; 65(12):589-91. PubMed ID: 5000186
[No Abstract] [Full Text] [Related]
45. [Pharmacokinetics of nitrate derivatives: recent data].
Baligadoo S; Chiche P
Coeur Med Interne; 1979; 18(2):263-8. PubMed ID: 114351
[No Abstract] [Full Text] [Related]
46. [Comparative study of three oral nitrate derivatives. A hemodynamic assessment in 10 patients with chronic heart failure (author's transl)].
Bory M; Clavier P; Arnoux F; Djiane P; Egre A; Serradimigni A
Nouv Presse Med; 1980 Sep; 9(34 Suppl):2437-42. PubMed ID: 6775296
[TBL] [Abstract][Full Text] [Related]
47. The therapeutic role of coronary vasodilators: glyceryl trinitrate, isosorbide dinitrate, and pentaerythritol tetranitrate.
Russek HI
Am J Med Sci; 1966 Jul; 252(1):9-20. PubMed ID: 4957459
[No Abstract] [Full Text] [Related]
48. Effects of nonintermittent treatment of rabbits with pentaerythritol tetranitrate on vascular reactivity and superoxide production.
Kojda G; Hacker A; Noack E
Eur J Pharmacol; 1998 Aug; 355(1):23-31. PubMed ID: 9754935
[TBL] [Abstract][Full Text] [Related]
49. Significant labeling and dosing changes for isosorbide dinitrate.
Drown DJ
Prog Cardiovasc Nurs; 1997; 12(4):32-3. PubMed ID: 9433732
[No Abstract] [Full Text] [Related]
50. Effects of several antianginal agents on pacing-induced S-T Segment depression in the atherosclerotic rabbit.
Baky SH; Lee RJ
Proc Soc Exp Biol Med; 1975 Mar; 148(3):834-7. PubMed ID: 1129307
[TBL] [Abstract][Full Text] [Related]
51. [Drug treatment of chronic coronary disease].
Halawa B
Wiad Lek; 1980 Jan; 33(2):107-11. PubMed ID: 6768197
[No Abstract] [Full Text] [Related]
52. The effect of high-dose pentaerythritol tetranitrate on the development of nitrate tolerance in rabbits.
Müllenheim J; Müller S; Laber U; Thämer V; Meyer W; Bassenge E; Fink B; Kojda G
Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3):269-75. PubMed ID: 11521170
[TBL] [Abstract][Full Text] [Related]
53. [Mechanisms and clinical significance of nitrate tolerance].
Daiber A; Gori T; Münzel T
Pharm Unserer Zeit; 2010 Sep; 39(5):375-84. PubMed ID: 20818687
[No Abstract] [Full Text] [Related]
54. NO-donors and angina pectoris: more than just symptomatic treatment?
Cleophas TJ; Niemeyer MG
Neth J Med; 1997 Apr; 50(4):180-3. PubMed ID: 9130843
[No Abstract] [Full Text] [Related]
55. Prophylactic therapy of angina pectoris with organic nitrates: relationship of drug efficacy and clinical experimental design.
Stipe AA; Fink GB
J Clin Pharmacol; 1973 Jul; 13(7):244-50. PubMed ID: 4197275
[No Abstract] [Full Text] [Related]
56. Bioactivation of organic nitrates and the mechanism of nitrate tolerance.
Klemenska E; Beresewicz A
Cardiol J; 2009; 16(1):11-9. PubMed ID: 19130411
[TBL] [Abstract][Full Text] [Related]
57. [Treatment of coronary insufficiency with a combination of 2 nitro-derivatives. Controlled pluricentric clinical trial].
Di Prisco AU; Vaccari GL; Soro A; Mora A
Minerva Med; 1975 Feb; 66(12):551-61. PubMed ID: 1113905
[TBL] [Abstract][Full Text] [Related]
58. [Treatment of coronary angina. Use of a delayed-action nitrate derivative].
Giard
J Sci Med Lille; 1972 Nov; 90(11):407-10. PubMed ID: 4650213
[No Abstract] [Full Text] [Related]
59. Efficacy of the long-acting nitro vasodilator pentaerithrityl tetranitrate in patients with chronic stable angina pectoris receiving anti-anginal background therapy with beta-blockers: a 12-week, randomized, double-blind, placebo-controlled trial.
Münzel T; Meinertz T; Tebbe U; Schneider HT; Stalleicken D; Wargenau M; Gori T; Klingmann I;
Eur Heart J; 2014 Apr; 35(14):895-903. PubMed ID: 24071762
[TBL] [Abstract][Full Text] [Related]
60. [Clinical use of a combination of butydrine and pentaerythrol in coronary insufficiency].
Ballerini A
Minerva Cardioangiol; 1971 May; 19(5):272-6. PubMed ID: 4397515
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
